Show simple item record

Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy

dc.contributor.authorSari, Murat
dc.contributor.authorAYDINER, Adnan
dc.date.accessioned2021-03-05T10:00:23Z
dc.date.available2021-03-05T10:00:23Z
dc.date.issued2018
dc.identifier.citationAYDINER A., Sari M., "Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy", JOURNAL OF CLINICAL ONCOLOGY, cilt.36, 2018
dc.identifier.issn0732-183X
dc.identifier.othervv_1032021
dc.identifier.otherav_a0c76155-ad98-4862-b2b3-6ac7d6c1f99d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/107798
dc.identifier.urihttps://doi.org/10.1200/jco.2018.36.15_suppl.e21212
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleEpidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGY
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume36
dc.identifier.issue15
dc.contributor.firstauthorID2359659


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record